Jazz Pharmaceuticals to Present at UBS Global Life Sciences Conference
PALO ALTO, Calif., Sept. 11 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that Samuel Saks, M.D., the company's Chief Executive Officer, will provide a corporate presentation at the UBS Life Sciences Conference in New York, NY on September 24, 2007 at 4:00 p.m. Eastern time.
A live webcast of the presentation may be accessed by visiting the Investors section of the Jazz Pharmaceuticals website at http://www.JazzPharmaceuticals.com. A replay will be available on Jazz Pharmaceuticals' website until October 8, 2007.
About Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.
For further information see http://www.JazzPharmaceuticals.com.
SOURCE Jazz Pharmaceuticals, Inc.
CONTACT: Jim Karrels, Executive Director, Finance, of Jazz Pharmaceuticals, Inc.
Web site: http://www.jazzpharmaceuticals.com